These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 12567657

  • 1. [Plasmodium falciparum: antimalarial activities of antisense oligodeoxyribonucleotides targeted to histidine-rich protein genes in vitro].
    Yu XB, Fang JM, Luo SH.
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2000; 18(4):200-3. PubMed ID: 12567657
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of malarial topoisomerase II in Plasmodium falciparum by antisense nanoparticles.
    Föger F, Noonpakdee W, Loretz B, Joojuntr S, Salvenmoser W, Thaler M, Bernkop-Schnürch A.
    Int J Pharm; 2006 Aug 17; 319(1-2):139-46. PubMed ID: 16713146
    [Abstract] [Full Text] [Related]

  • 3. Delayed parasite elimination in human infections treated with clindamycin parallels 'delayed death' of Plasmodium falciparum in vitro.
    Burkhardt D, Wiesner J, Stoesser N, Ramharter M, Uhlemann AC, Issifou S, Jomaa H, Krishna S, Kremsner PG, Borrmann S.
    Int J Parasitol; 2007 Jun 17; 37(7):777-85. PubMed ID: 17280676
    [Abstract] [Full Text] [Related]

  • 4. Plasmodium falciparum: effect of chemical structure on efficacy and specificity of antisense oligonucleotides against malaria in vitro.
    Barker RH, Metelev V, Coakley A, Zamecnik P.
    Exp Parasitol; 1998 Jan 17; 88(1):51-9. PubMed ID: 9501848
    [Abstract] [Full Text] [Related]

  • 5. [Cloning and sequence analysis of histidine-rich protein-II gene fragment of Plasmodium falciparum yunnan strain].
    Xiao J, Li M, Bi H, Wang P, Li Y.
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 1999 Jan 17; 17(3):143-5. PubMed ID: 12563830
    [Abstract] [Full Text] [Related]

  • 6. Inhibitory effect of antisense oligodeoxynucleotide to p44/p42 MAPK on angiotensin II-induced hypertrophic response in cultured neonatal rat cardiac myocyte.
    Zhang SQ, Ding B, Guo ZG, Li YX.
    Acta Pharmacol Sin; 2004 Jan 17; 25(1):41-6. PubMed ID: 14704121
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Comparison of a SYBR green I-based assay with a histidine-rich protein II enzyme-linked immunosorbent assay for in vitro antimalarial drug efficacy testing and application to clinical isolates.
    Bacon DJ, Latour C, Lucas C, Colina O, Ringwald P, Picot S.
    Antimicrob Agents Chemother; 2007 Apr 17; 51(4):1172-8. PubMed ID: 17220424
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Synthesis and evaluation of sulfonylurea derivatives as novel antimalarials.
    León C, Rodrigues J, Gamboa de Domínguez N, Charris J, Gut J, Rosenthal PJ, Domínguez JN.
    Eur J Med Chem; 2007 Jun 17; 42(6):735-42. PubMed ID: 17321641
    [Abstract] [Full Text] [Related]

  • 12. Antimalarial effect of N-acetyl-L-Leucyl-L-leucyl-L-norleucinal by the inhibition of Plasmodium falciparum Calpain.
    Jung SY, Zheng B, Choi YY, Soh BY, Kim SY, Park KI, Park H.
    Arch Pharm Res; 2009 Jun 17; 32(6):899-906. PubMed ID: 19557368
    [Abstract] [Full Text] [Related]

  • 13. [In vitro antiviral activity of antisense oligonucleotides against influenza virus].
    Chen Z, Wang S, Guan W, Yang B, Sun Z.
    Wei Sheng Wu Xue Bao; 2000 Oct 17; 40(5):482-7. PubMed ID: 12548758
    [Abstract] [Full Text] [Related]

  • 14. In vitro efficiency of new acridyl derivatives against Plasmodium falciparum.
    Guetzoyan L, Ramiandrasoa F, Dorizon H, Desprez C, Bridoux A, Rogier C, Pradines B, Perrée-Fauvet M.
    Bioorg Med Chem; 2007 May 01; 15(9):3278-89. PubMed ID: 17339112
    [Abstract] [Full Text] [Related]

  • 15. Activity of azithromycin or erythromycin in combination with antimalarial drugs against multidrug-resistant Plasmodium falciparum in vitro.
    Nakornchai S, Konthiang P.
    Acta Trop; 2006 Dec 01; 100(3):185-91. PubMed ID: 17126280
    [Abstract] [Full Text] [Related]

  • 16. Potentiation of antimalarial drug action by chlorpheniramine against multidrug-resistant Plasmodium falciparum in vitro.
    Nakornchai S, Konthiang P.
    Parasitol Int; 2006 Sep 01; 55(3):195-9. PubMed ID: 16750932
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The A/T-specific DNA alkylating agent adozelesin inhibits Plasmodium falciparum growth in vitro and protects mice against Plasmodium chabaudi adami infection.
    Yanow SK, Purcell LA, Spithill TW.
    Mol Biochem Parasitol; 2006 Jul 01; 148(1):52-9. PubMed ID: 16597469
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.